A fundamental question in development is how cells assemble to form a tubular network during organ formation. In glandular organs, tubulogenesis is a multistep process requiring coordinated proliferation, polarization and reorganization of epithelial cells to form a lumen, and lumen expansion. Although it is clear that epithelial cells possess an intrinsic ability to organize into polarized structures, the mechanisms coordinating morphogenetic processes during tubulogenesis are poorly understood. Here, we demonstrate that parasympathetic nerves regulate tubulogenesis in the developing salivary gland. We show that vasoactive intestinal peptide (VIP) secreted by the innervating ganglia promotes ductal growth, leads to the formation of a contiguous lumen, and facilitates lumen expansion through a cyclic AMP/ protein kinase A (cAMP/PKA)-dependent pathway. Furthermore, we provide evidence that lumen expansion is independent of apoptosis and involves the cystic fibrosis transmembrane conductance regulator (CFTR), a cAMP-regulated Cl(À) channel. Thus, parasympathetic innervation coordinates multiple steps in tubulogenesis during organogenesis.
INTRODUCTION
Tubulogenesis during glandular development results in the establishment of a complex network of epithelial ducts with terminal acini (Lubarsky and Krasnow, 2003) . Whereas subcellular mechanisms govern polarization of individual and neighboring epithelial cells, formation of a complex tubular network in vivo largely relies on interactions with the stroma, which consists of endothelial, mesenchymal, and neuronal cells, as well as the extracellular matrix (reviewed by Iruela-Arispe and Beitel, 2013). Despite the progress made toward our understanding of tubulogenesis, the mechanisms controlling coordi-nated behavior of epithelial cells to form a functional tube remains poorly understood.
A potential mechanism to coordinate epithelial tubulogenesis involves the parasympathetic branch of the autonomic nervous system, which innervates all tubular organs including the lungs, prostate, and salivary glands. The developing submandibular gland (SMG) (embryonic day [E] 11.5-15) is innervated by the parasympathetic, but not sympathetic or sensory, nerves of the parasympathetic submandibular ganglion (PSG) (Proctor and Carpenter, 2007) . Ductal tubulogenesis is also occurring in parallel with parasympathetic innervation. We recently showed that the PSG maintains a reservoir of undifferentiated keratin (K) 5 (+) progenitor cells via an acetylcholine (ACh)/muscarinic (M1) receptor/epidermal growth factor receptor (EGFR)-dependent pathway in the ex vivo embryonic SMG (Knox et al., 2010) . Signals from the PSG also control the function of adult SMG and also maintain epithelial architecture, as tissue degeneration results from parasympathetic denervation of rodent or human salivary gland epithelium (Kang et al., 2010; Kyriacou and Garrett, 1988; Mandour et al., 1977) . However, it is unclear whether the role of innervation is exclusively to drive progenitor cell proliferation, thereby ensuring a sufficient supply of epithelial cells, or if this role extends to direct regulation of epithelial tubulogenesis (e.g., cell polarization and duct and lumen formation).
Here, we show that parasympathetic nerves play a multifunctional role in tubulogenesis during SMG organogenesis. Ductal tubulogenesis in the SMG requires differentiated luminal cells (K19[+]) to proliferate and then condense at the midline, which occurs at E13.5. These cells polarize to form microlumens that coalesce to form a contiguous ductal lumen (Hieda et al., 1996 ; $E14; Figure 1A and Figure S1 available online). Finally, the lumen expands for the passage of liquids ( Figure 1A ). During this process, axon bundles migrate from the PSG along the basement membrane surrounding the ductal epithelium to envelope the end buds (Coughlin, 1975; Knox et al., 2010) . Nerve-derived factors released from varicosities (nonconventional synapses) on the axons diffuse toward the epithelium, thus establishing neuronal-epithelial communication. Here, we identify neuronal-derived vasoactive intestinal peptide (VIP) as an important regulator of key steps during epithelial tubulogenesis. VIP activates the cyclic AMP (cAMP)/protein kinase A (PKA) pathway to increase duct elongation through cell proliferation and the subsequent formation of a single contiguous lumen through fusion of multiple microlumens. Once the lumen has formed, VIP is also required for its expansion via a cAMP/PKA/ cystic fibrosis transmembrane conductance regulator (CFTR)dependent pathway.
RESULTS

Ductal Tubulogenesis Is Aberrant in the Absence of Parasympathetic Innervation
Based on the parallel development of nerves and epithelium, we postulated that neuronal signals modulate ductal tubulogenesis. To test this hypothesis, we inhibited neuronal outgrowth and function in E13 SMG ex vivo cultures using a function-blocking antibody to the neurotrophic factor neurturin (NRTN). NRTN is secreted by the end buds and binds its cognate receptor GFRa2 on the nerves to promote neuronal outgrowth, function, and survival (Knox et al., 2013) . Similar to our prior study, inhibition of NRTN signaling resulted in reduced nerve outgrowth and deficient innervation of the epithelium as well as decreased epithelial branching (Figures 1B and 1C; Knox et al., 2013) . To examine ductal tubulogenesis, (iii) microlumens coalesce to form a contiguous apical membrane bounding a luminal space; and (iv) lumen undergoes expansion. (B-D) E13 SMGs were isolated and treated with anti-NRTN function blocking antibody for 24 hr before being fixed and immunostained for nerves (C; Tubb3, green) and ZO1(+) tight junctions (D, white) . Arrowheads highlight ZO1 at the ductal midline. The scale bars represent 50 mm (C) and 20 mm (D). (C) is a 30 mm projection of 1.5 mm confocal sections. (D) is a 12 mm projection of 1 mm confocal sections. See also Figure S1 .
we used the tight junction marker protein zona occludin-1 (ZO1). ZO1(+) tight junctions form at the border between basolateral and apical (luminal) membranes and thus can be used to highlight sites of ductal lumen formation ( Figure S1 ). In control SMG, ZO1 immunostaining revealed an interconnected network of tight junctions demarcating the developing ductal lumen ( Figure 1D ; control immunoglobulin G [IgG]). However, in anti-NRTN-treated SMG, ZO1(+) structures were distributed throughout the epithelium, with little to no localization at the ductal midline or interconnections between individual structures ( Figure 1D , lower panel). Thus, loss of NRTN/GFRa2 signaling and consequently innervation disrupts lumen formation during SMG development.
VIP/VIPR1, but Not ACh/M1, Signaling Is Required for Ductal Tubulogenesis Given that neuronal ACh increases SMG growth by activating epithelial muscarinic receptors (Knox et al., 2010) , we asked whether muscarinic signaling also regulates ductal tubulogenesis. Culture of intact E12.5 SMG with the muscarinic antagonist 1,1-dimethyl-4-diphenylacetoxypiperidinium iodide (4-DAMP) for 48 hr decreased epithelial branching (Figures 2A and 2B ), as previously reported (Knox et al., 2010) . However, it did not prevent K19(+) cells from condensing at the ductal midline or affect the distribution of ZO1(+) tight junctions (Figures 2B and 2C) . Indeed, 4-DAMP-treated SMG formed narrower elongated ducts with smaller end buds compared to control, as illustrated by time-lapse imaging (Movie S1). Thus, ACh/M1 signaling is not strictly required for ductal tubulogenesis in the developing SMG.
As the loss of functional innervation that results in abnormal ductal tubulogenesis is not recapitulated by muscarinic antagonism (Figures 1D and 2A-2C; Movie S1), we speculated that a different neurotransmitter was involved. To identify neurotransmitters and their receptors that might regulate this process,
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Nerves Coordinate Epithelial Tubulogenesis Figure 2 . Ductal Tubulogenesis Requires VIP/VIPR1, but Not ACh/M1 Signaling (A-D) E13 SMGs were cultured with the muscarinic receptor antagonist, 4-DAMP (10 mM) or VIPR1 antagonist (VIPR1ant; 30 mM) for 24 hr and shown are (A) overall architecture of the SMG, (B) branch number and duct width, (C) distribution of K19 (red) and ZO1 (green) with E-cadherin (Ecad, blue), and (D) microarray analysis of gene expression in SMG from embryonic days 12-17 and postnatal (P) days 1 and 5. Shown are relative expression levels (normalized to the highest expression level). The scale bar in (C) represents 50 mm. (E) SMG epithelial and mesenchymal compartments were separated, and expression of VIP and VIPR1 were analyzed by qPCR. (F) E13 PSGs were isolated and immunostained for neurons (Tubb3, red) and VIP (green), or E13.5 SMG were immunostained for Ecad (red) and VIPR1 (green). (G) Vip-Cre mice were crossed to a Rosa26 mTmG reporter strain and the salivary glands analyzed at E14 and P1. Images represent 10-15 mm projections of 1 mm confocal sections. The scale bar represents 50 mm. (H) E13 PSGs were treated with 10 ng/ml NRTN for 24 hr and changes in gene expression quantified by qPCR. (I and J) E13 SMG were cultured with the muscarinic receptor antagonist, 4-DAMP (10 mM) or VIPR1ant (30 mM) for 24 hr and (I) neuronal outgrowth (Tubb3, red) and VIP protein (green) or (J) expression of neuronal marker transcripts were analyzed. In (H) and (J), control expression was set to 1 (dashed line). Fluorescent images are 12 mm projections of 1 mm sections (in C) or 25 mm projection of 1.5 mm sections (in I). The scale bar in (I) represents 50 mm. In (B), (H), and (J), data are means ± SD for three experiments. In (B), data were analyzed using a one-way ANOVA with post hoc Dunnett's test; in (H) and (J), a false discovery rate (Q) for multiple unpaired t tests was set to 5%; *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S2 .
Nerves Coordinate Epithelial Tubulogenesis we analyzed an existing microarray data set of the developing SMG (E11-adult; http://sgmap.nidcr.nih.gov/sgmap/sgexp. html). We searched for genes that were upregulated during duct development and/or were coregulated with the ductal epithelial markers Krt19, Cldn7 (claudin-7), and Krt7. Using this strategy, we found that expression of the VIP receptor, VIPR1, tightly clustered with the ductal markers ( Figure 2D ). In addition, the ligand for VIPR1, the neuropeptide VIP ( Figure 2D ), but not other parasympathetic neurotransmitters (NPY, tachykinin, and neuropeptide b; data not shown), increased at the initiation of secondary duct formation (E13) and lumenization (E13.5). Further analysis of the tissue distribution of VIP and VIPR1 expression by quantitative PCR (qPCR) and immunohistochemistry revealed that VIPR1 was highly expressed in the epithelium (Figures 2E and 2F) and a subpopulation of neuronal cells (data not shown). In contrast, VIP was enriched in the PSG (Figures 2E and 2F) and absent in epithelial tissue. The absence of VIP from the epithelium was further confirmed by genetic lineage tracing in which VIP-Cre transgenic mice (Taniguchi et al., 2011) were crossed to a Rosa26 mTmG reporter strain ( Figure 2G ). Lastly, we found that expression of Vip, but not other neuropeptides, was significantly increased in the PSG upon NRTN stimulation ($6.1-fold; Figure 2H ), suggesting that epithelial NRTN actively promotes VIP secretion by the nerves.
Treatment of SMGs with a specific and well-characterized VIPR1 peptide antagonist (VIPR1ant) (Ceraudo et al., 2012; Gourlet et al., 1997; Figures 2A and 2B) or knockdown of Vipr1 using small interfering RNA ( Figures S2A-S2D ) reduced the number of epithelial branches, similar to treatment with 4-DAMP (Figures 2A and 2B ) or anti-NRTN-function-blocking antibody ( Figure 1B ; Knox et al., 2013) . In contrast to both control and 4-DAMP-treated SMG, VIPR1ant-treated glands exhibited significantly wider K19(+) ducts ( Figures 2B and 2C ) and impaired condensation of K19(+) ductal cells and ZO1(+) tight junctions at the midline ( Figures 2C and S2A ). This effect was not due to the loss of innervation or neuronal defects, as VIPR1ant treatment did not reduce (or increase) axon outgrowth (Figures 2I and S2E) or neuronal gene expression ( Figure 2J ).
In addition to increasing expression of genes involved in ACh/ muscarinic signaling (Vacht; 2-fold) and synapse formation (Syn2; 2.6-fold; Figure 2J ), 4-DAMP treatment of E13 SMGs caused a striking increase in innervation and VIP protein (Figures 2I, middle panel, yellow, and S2E, middle panel) and to a lesser extent Vip transcript (1.6-fold; Figure 2J ). We speculated that this increase in VIP is responsible for the more-ductal appearance of the muscarinic-receptor-antagonized SMG (Figures 2A-2C ; Movie S1). This notion prompted us to determine if exogenous VIP could increase duct tubulogenesis. E13 SMGs were treated with VIP for 24 hr, and they resembled the 4-DAMP phenotype: end buds were smaller in size, ducts were narrower, and condensation of K19(+) cells at the ductal midline increased (Figures S2F and S2G) . Together, these data indicate that ductal tubulogenesis in the SMG is regulated by the PSG through a VIP/VIPR1-dependent mechanism.
VIP Is Sufficient to Mediate the Effect of the PSG on Ductal Epithelial Growth To confirm the role of the PSG and VIP in ductal tubulogenesis, we employed epithelial cultures devoid of mesenchyme and nerves (Steinberg et al., 2005) . We first tested whether a physical interaction between the epithelium and nerves was required to regulate morphogenesis by coculturing epithelia with $4 or 5 PSG explants placed at a distance from the epithelium. To promote VIP production by the PSG, NRTN was added to the media. Epithelia cocultured with PSGs displayed increased branching and ductal growth as compared to epithelia cultured alone, indicating that a direct interaction between nerves and epithelium was not required ( Figures 3A and 3B ). To determine if VIP produced by PSG was responsible for epithelial morphogenesis, we inhibited VIPR1. The VIPR1ant abrogated the effect of the PSG on ductal length, but not the number of branches ( Figures 3A and 3B ). Interestingly, this was in contrast to the reduced branching observed in intact SMGs cultured with VIPR1ant (Figures 2A and 2B) , suggesting that other neuronal-derived factors may promote epithelial bud formation independently of VIP (Knox et al., 2010) .
To confirm that VIP was sufficient to induce ductal growth in the SMG, we treated isolated epithelial rudiments in the absence of nerves with VIP. This mimicked the effect of the PSG on ductal tubulogenesis, causing a significant increase in branch number and ductal length ( Figures 3C and 3E ). Furthermore, VIP increased proliferation of cells in ducts by $2.7-fold over controls, as assayed by 5-ethynyl-2 0 -deoxyuridine (EdU) incorporation ( Figures  3C-3E ). Most of these EdU(+) ductal cells were K19(+) ( Figure 3D ), indicating that luminal cells are the primary targets of VIP in SMG epithelium. Consistent with this, K19(+) ductal cells expressed VIPR1 ( Figure S3 ). Together, these data demonstrate that VIP from the PSG is sufficient to induce ductal growth in the SMG via expansion of the K19(+) luminal population.
VIP Is Required for Formation of Contiguous Ductal Lumen
A functional duct requires the creation of a contiguous lumen. For several tubular organs, including the salivary gland, epithelial cell polarization results in multiple microlumens that fuse to form a contiguous lumen (Figures 1A and S1B; Movie S2; Bagnat et al., 2007; Hieda et al., 1996; Kesavan et al., 2009; Walker et al., 2008; Yang et al., 2013) . However, the signaling events that elicit formation of a single lumen are not known. We investigated the effect of VIP on cell polarization and lumen formation in the SMG ( Figure 3F ) by culturing E13 epithelia with exogenous VIP for 48 hr. Cell polarity and lumen formation were analyzed using an apical marker atypical protein kinase C (aPKC), GM130 (a Golgi marker with subapical localization), and the epithelial cell-cell adhesion protein E-cadherin (Ecad) as a lateral/basal marker. In the absence of VIP, ductal cells polarized along the ductal axis to form small apical patches or microlumens enriched in aPKC and GM130 (Figures 3G and 3H, upper panel, arrow heads) . However, in the presence of VIP, a contiguous lumen formed, as marked by apical aPKC and subapical GM130 (Figures 3G and 3H, lower panel) . Nuclei staining further confirmed a single lumen in VIP-treated epithelia ( Figure 3G ). Thus, whereas ductal cells can polarize and form microlumens in the absence of VIP, the formation of a single contiguous lumen requires VIP.
VIP Promotes Ductal Growth and Lumen Formation in a cAMP-Dependent Manner VIPR1 belongs to the Gs protein-coupled class of receptors, whose activation results in elevation of cAMP and subsequent
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Nerves Coordinate Epithelial Tubulogenesis activation of cAMP-dependent PKA. Therefore we asked if VIP coordinates tubulogenesis in a cAMP/PKA-dependent manner. Treatment of epithelial rudiments with VIP increased cAMP and phosphorylation of the PKA target cAMP-response-elementbinding protein (CREB) ( Figures 4A and 4B ). Supporting the role of cAMP in ductal tubulogenesis, the membrane-permeable cAMP analog, 8-bromoadenosine-3,5-cyclic monophosphate (8-Br-cAMP), mimicked the effect of VIP on epithelial ductal growth (Figures 4C and 4D) and induced formation of a contiguous lumen, with apical enrichment of F-actin and subapically located GM130 ( Figure 4D ). Moreover, the selective PKA inhibi- tor Rp-CPT-cAMPS abrogated both VIPmediated ductal elongation in epithelial rudiment culture (Figures S4A and S4B ) and lumen formation in intact salivary gland explants (containing PSG), as highlighted by the luminal marker prominin-1 (Prom1) ( Figure 4E ). Thus, VIP regulates ductal growth and formation of a contiguous lumen via cAMP/PKA signaling.
VIP-Induced Lumen Formation Does Not Require Apoptosis
Apoptosis is a potential mechanism for lumen formation in several glandular organs including mammary and salivary glands (Humphreys et al., 1996; Mailleux et al., 2007) . To determine whether apoptosis mediates VIP-dependent lumen formation in salivary glands, we inhibited apoptosis by culturing E13.5 SMGs with the pan-caspase inhibitor Z-VAD-FMK for 24 hr (Figures S4A and S4B) . Consistent with previous reports for cultured SMG (Hoffman et al., 2002; Walker et al., 2008; Patel et al., 2011) , apoptosis occurs in the mesenchyme, with few apoptotic cells within the branching epithelium (or lumens; Figures 5A and  5B ). In the presence of Z-VAD-FMK, mesenchymal and epithelial cell death was not observed ( Figure 5B ), yet epithelial lumens formed and were similar to the untreated SMG ( Figure 5A ). To confirm that apoptosis did not mediate lumen formation in SMGs in vivo, we assessed the ductal system of SMG derived from E17 mice deficient in the proapoptotic factor, Bax. Baxnull SMGs were phenotypically normal, with a tubular ductal system similar to wild-type controls ( Figure 5C ). Thus, from these studies, we conclude that VIP-mediated lumen formation in the SMG is not dependent on apoptosis.
VIP Rapidly Expands Ductal Lumens in a cAMP/PKA-and CFTR-Dependent Manner After a nascent lumen is formed, it must expand for fluid transport. Multiple mechanisms of lumen expansion have been identified including solutes and water transport, secretion of luminal matrix, or polarized vesicular transport (reviewed in Datta et al., 2011) . Because VIP enlarges lumens of spherical epithelial cysts in vitro (Talbot et al., 2002) , we asked whether VIP also regulates lumen expansion in the SMG. VIP treatment of SMG explants led to a rapid expansion of the primary duct lumen compared to the untreated control (asterisks in Figure S2F and arrowheads in Figure S5A) . Because the primary duct already contains a mature lumen when the gland is isolated for ex vivo culture, these data indicate that VIP regulated lumen expansion directly, independently of its polarizing effect on ductal cells.
To further test whether VIP-mediated lumen expansion was independent of its effects on growth and lumen formation, we modified our epithelial rudiment culture to exclude the effect of VIP on these parameters. Epithelia were cultured for 28-30 hr in the presence of HBEGF, which increases duct cell proliferation (Knox et al., 2010) and promotes formation of elongated secondary ducts with multiple microlumens ( Figure 6A ). Importantly, despite its prominent effect on ductal growth, HBEGF was not able to promote formation of a single contiguous lumen. To study the role of VIP in lumen expansion, epithelia were then treated with and without VIP as well as agonists and antagonists of PKA for 1 hr ( Figure 6A ). Both VIP and the cAMP analog, 8-CPT-cAMP, initiated the expansion of microlumens, which partially coalesced to form larger lumens ( Figures 6B and S5B) . In contrast, the ACh analog carbachol (CCh), which does not increase cAMP, did not induce lumen expansion ( Figure S5B ). Further experiments demonstrated that VIP-induced lumen expansion requires activation of PKA. First, VIP-induced lumen expansion was abolished by the PKA inhibitor, Rp-CPT-cAMPS ( Figures 6B and S5B) . Second, 8-pCPT-2 0 -O-Me-cAMP, a selective activator of another major cAMP target, the exchange protein directly activated by cAMP (Epac), did not induce lumen expansion, whereas structurally similar 8-CPT-cAMP, which activates both PKA and Epac, did ( Figures 6B and S5B ). Together, these data indicate that cAMP/ PKA-dependent signaling is required and sufficient for lumen expansion and that the effect of VIP on lumen expansion is not only due to its mitogenic role in duct elongation.
PKA regulates lumen expansion through increased flow of electrolytes and fluid transport (Bagnat et al., 2010; Jaffe et al., 2008) , as well as apoptosis of luminal cells (Nedvetsky et al., 2012) . Using live-cell imaging of epithelia labeled with membrane-bound red fluorescent protein (RFP), we observed luminal cavities that appear and expand within 10 min of adding VIP (Figure 6C) . The fast nature of lumen expansion and the lack of isolated cells ( Figure 6B ) or cleaved caspase-3(+) apoptotic cells (data not shown) within newly forming lumens (<1 hr) suggested that lumen expansion was driven by electrolyte and fluid flow rather than apoptosis. We identified CFTR as a likely candidate as it regulates cAMP-dependent lumen expansion in zebrafish (Bagnat et al., 2010) , VIP enhances CFTR activity and localization at the apical membrane of epithelial cells (Chappe et al., Qu et al., 2011) , and CFTR protein is enriched in SMG ducts at the presumptive lumen during development ( Figures  S5C and S5D ). Upon inhibition of CFTR using the specific inhibitor CFTRinh-172, VIP-mediated lumen expansion was inhibited to a similar extent as the PKA inhibitor, Rp-CPT-cAMPS ( Figures  6B and S5B) . Importantly, the presence of CFTRinh-172 did not affect the polarization of ductal cells and formation of contiguous lumen ( Figure S5E ). Thus, VIP/VIPR1 promotes lumen formation and expansion through different mechanisms with the CFTRdependent pathway involved in lumen expansion, but not lumen formation.
VIP-Dependent Innervation Coordinates SMG Tubulogenesis In Vivo
Next, we tested whether VIP(+) parasympathetic nerves coordinates SMG tubulogenesis in vivo using mice deficient in the nerve-derived factor neuregulin 1 type III (Nrg1-III) (Wolpowitz et al., 2000) . These mice show depleted innervation of numerous tissues, dying from respiratory failure at birth. Nrg1-III-deficient salivary glands were devoid of functional nerves and exhibited aberrant ductal morphogenesis: epithelial branching was reduced ( Figures 7A and 7B ) with disrupted lumen formation ( Figure 7A ; ZO1 immunostaining, lower panel) and expansion ( Figures 7D and 7E, arrows) . We next asked whether this phenotype was due to loss of fibroblast growth factor 10 (FGF10)/ FGFR2b signaling, an essential regulator of epithelial branching in the SMG (Jaskoll et al., 2005) . However, expression of Fgf10 and FGFR2b targets, Etv4 and Etv5, were unchanged ( Figure 7C ). In addition, reduction of FGF10/FGFR2b signaling ex vivo (Figure S6A; Steinberg et al., 2005) or in vivo ( Figure S6B ; Jaskoll et al., 2005) had no effect on ductal development. Together, these data indicate that deficient VIP-dependent innervation results in impaired SMG tubulogenesis in vivo.
To determine whether reduced VIP/VIPR1 signaling decreased tubulogenesis similar to that observed in the absence of parasympathetic nerves in vivo ( Figures 7A and 7D) , we inhibited VIPR1 during in vivo SMG development (E12-E16) using the VIPR1 antagonist. Pregnant mice were injected with VIPRant between E12 and E16, as described previously (Gressens et al., 1994; Passemard et al., 2011) , and lumen formation was analyzed at E17.5. Strikingly, the luminal cavities of salivary glands from VIPRant-treated embryos were smaller than those of the glands from control embryos (PBS only; Figures 7F and  7G) , confirming that VIP is necessary for lumen expansion. We did not find lumen formation to be disrupted (data not shown). However, this may be due to the concentration of VIPR1ant being too low to inhibit this process or additional factors compensating for VIPR1 inhibition.
Lastly, we asked if CFTR was required for tubulogenesis in vivo using SMG derived from Cftr-deficient mice (Snouwaert et al., 1992) . Compared to wild-type controls, Cftr-null SMG exhibited aberrant tubulogenesis as shown by the absence of large granulated ducts ( Figure 7H ; see arrow in wild-type), thus confirming a role for CFTR in epithelial tubulogenesis in the SMG.
DISCUSSION
Previous studies of tubulogenesis have highlighted a role of multiple molecular pathways (reviewed by Iruela-Arispe and Beitel, 2013) . However, mechanisms coordinating morphogenic processes during tubulogenesis are poorly understood. Our data reveal that parasympathetic nerves serve to coordinate epithelial tubulogenesis in the developing salivary gland. We demonstrate that the neurotransmitter VIP and its receptor VIPR1 regulate multiple steps during epithelial tubulogenesis that include cell proliferation, duct elongation, lumen formation, and lumen expansion ( Figure 7I ; Knox et al., 2010) , thus linking epithelial tubulogenesis with parasympathetic neuronal function. Lastly, we identify a potential mechanism whereby NRTN produced by the epithelium promotes functional nerve outgrowth to ensure parallel development of nerves and epithelium ( Figure 7I ).
Our studies also demonstrate that VIP and ACh have essential, nonoverlapping functions during duct formation. Proliferation of basal epithelial progenitor cells necessary for epithelial branching requires ACh/M1/EGFR signaling (Knox et al., 2010) . Other pathways, such as HBEGF/EGFR, promote luminal cell proliferation and differentiation during duct development ( Figure 7I ; Hä ä rä et al., 2009; Knox et al., 2010) , but do not compensate in the absence of functional innervation. Therefore, we propose HBEGF/EGFR to act in concert with parasympathetic signals during ductal tubulogenesis but that ACh and VIP are key regulators of events necessary to create a functional tubular network ( Figure 7I ).
Our study also provides an answer to one of the puzzling questions in the field of epithelial tubulogenesis: what factors orchestrate the formation of a contiguous lumen? Microlumen formation relies on the intrinsic ability of epithelial cells to polarize (Sternlicht et al., 2006) , but the signaling events controlling microlumen fusion to establish a common single lumen are just beginning to emerge (Iruela-Arispe and Beitel, 2013). Our study indicates that, at least in the SMG, transition from multiple microlumens to a single contiguous lumen requires the external neuronal factor VIP. Because this process of lumenization also occurs in other epithelial tissues innervated by VIP-secreting nerves, such as the pancreas, kidney, and intestine (Bagnat et al., 2007; Kesavan et al., 2009; Yang et al., 2013) , VIP-dependent innervation may also regulate formation of a contiguous lumen in these organs.
We also show that VIP(+) nerves activate PKA during development to regulate multiple steps during ductal tubulogenesis. 
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Nerves Coordinate Epithelial Tubulogenesis Figure 7 . Depletion of VIP+ Innervation In Vivo Abrogates Epithelial Branching, Lumen Formation, and Lumen Expansion (A and B) E14 salivary glands derived from Nrg1-III-null embryos cultured 24 hr before buds were counted (B) and tissue was fixed and immunostained for ZO1 (gray). Images in (A), lower panel, are 20 mm projections of 2 mm confocal sections. Arrowheads highlight ZO1 accumulation in presumptive ducts. Data in (B) were analyzed by Student's t test. WT, wild-type. (C) qPCR analysis of Nrg1-III-null E14 SMGs (control dotted line at 1). Means ± SD from three experiments. In (C), a false discovery rate (Q) for multiple unpaired t tests was set to 5%; *p < 0.05; **p < 0.01; ***p < 0.001. (D and E) E17 SMG from wild-type and Nrg1-III-null mice. (F and G) Timed pregnant CD1 mice were injected 23 daily with VIPRant for 5 days; glands were analyzed at E17.5. In (D)-(G), E-cadherin (green) labels epithelium, Tubb3 (blue) neurons, and prominin-1 (Prom-1, red) lumens. (D) and (F) are epifluorescent images of 12 mm sections. Size of lumens in (D) and (F) was (legend continued on next page)
Nerves Coordinate Epithelial Tubulogenesis Pharmacological manipulations of PKA have been shown to affect epithelial cell polarity and morphogenesis in vitro (Nedvetsky et al., 2012; Tee et al., 2010) . However, we identify an endogenous upstream signal engaging PKA in the regulation of epithelial tubulogenesis. What remains to be determined is the identity of the signaling molecules downstream of VIP/VIPR1/PKA that promote the formation of a contiguous lumen from multiple discontinuous microlumens. One potential candidate for this process is the Hedgehog-signaling pathway. Exogenous Shh promotes lumen formation in cultured SMG (Hashizume and Hieda, 2006) , and the Shh receptor smoothened regulates coalescence of microlumens in developing zebrafish gut (Alvers et al., 2014) . In this study, Shh acts on the mesenchyme and not the epithelium, leading the authors to propose signaling from the mesenchyme supports tubulogenesis. Whether Shh regulates production of VIP, which is expressed by the nerves within the mesenchymal compartment, or functions downstream of VIP/VIPR1 remains to be seen.
The role of apoptosis in salivary gland lumen formation has been a matter of debate. Previous studies show cleaved caspase-3(+) cells within luminal duct regions of isolated SMGs (Wells and Patel, 2010) . However, conclusive evidence demonstrating a link between apoptosis and lumen formation has not been reported. Our findings argue against an essential role of apoptosis in lumen formation or expansion in the SMG and support the hypothesis that the formation of a contiguous ductal network is independent of apoptosis in the developing salivary gland.
Similar to what has been observed for cAMP-mediated lumen expansion in zebrafish gut development (Bagnat et al., 2007) , we found lumen expansion to be dependent at least in part on a VIPresponsive PKA/CFTR-dependent mechanism. Reduced lumen expansion and/or atresia of the intestine have been found in Vip-, Vipr1-, and Cftr-null animals (Fabricius et al., 2011; Hodges et al., 2008; Lelievre et al., 2007; Meyerholz et al., 2010) . Similarly, we show that formation of the ductal network in salivary gland derived from Cftr-null mice is impaired ( Figure 7H ). As Cftr, Vip, and Vipr1 are inactivated in all tissues, aberrant epithelial tubulogenesis may be a consequence of other events. However, our data support a direct role of VIP and CFTR in ductal lumen expansion. It remains to be determined how CFTR activity results in lumen expansion in the SMG. Given both PKA and CFTR promote fluid secretion in developing and adult tissues (Bagnat et al., 2010; Magenheimer et al., 2006; Seino and Shibasaki, 2005) , we predict that fluid secretion mediated by VIP/PKA/ CFTR also accounts for lumen expansion in the developing salivary gland.
In summary, we have identified parasympathetic nerves and specifically VIP and its downstream effectors PKA and CFTR as key regulators of epithelial tubulogenesis during salivary gland development. We find lumen formation and lumen expansion in SMG ducts to be regulated independently. Whereas both lumen formation and expansion required VIP/cAMP/PKAdependent signaling, only lumen expansion involves CFTR activity. Consequently, parasympathetic nerves function in two distinct processes of SMG tubulogenesis: lumen formation and lumen expansion. Such findings have significant implications for the repair, regeneration, and/or de novo generation of branching organs, where efficient transport of fluid and osmolates through an interconnected ductal system is vital to organ function (Aframian and Palmon, 2008) . Lastly, our data establish the parasympathetic nervous system as an important player in epithelial tubulogenesis during organogenesis, highlighting the multifunctional contribution of nerves to developmental processes.
EXPERIMENTAL PROCEDURES
Mouse Lines, Breeding, and Genotyping Strains used in this study include: CD1 (Harlan), Nrg1 tm1Lwr (targeted mutation in Nrg1 type III; provided by Dr. Lorna Role, NYU; Wolpowitz et al., 2000) , Vip tm1(cre)Zjh (Vip-Cre; provided by Dr. John Rubenstein, UCSF; Taniguchi et al., 2011) , Gt(Rosa)26Sor tm4(ACTB-tdTomato,-EGFP)Luo (Rosa26 mTmG ; Muzumdar et al., 2007; from Dr. Ophir Klein, UCSF) , Bax tm1Sjk (provided by Dr. Diana Laird, UCSF; Knudson et al., 1995) , and Cftr tm1Unc (Snouwaert et al., 1992) . All experiments were approved by the Institutional Animal Care and Use Committee at UCSF. For timed matings, the morning of plug detection was considered day 0.5 postcoitum. For lineage tracing, Vip-Cre mice were crossed with Rosa26 mTmG reporter mice to obtain salivary glands from embryonic day 14 and postnatal day 1 pups. Genotyping of mice was performed on tail biopsies by PCR and agarose gel electrophoresis using specific primers.
SMG Organ Culture SMG explants were cultured as previously described (Steinberg et al., 2005) . Briefly, freshly dissected SMG were plated on nucleopore filters over medium containing glucagon (control; 30 mM; Anaspec) or, when indicated, VIPR1 peptide antagonist (30 mM; Phoenix Pharmaceuticals), the pan-caspase inhibitor Z-VAD-FMK (50 mM; Tocris Bioscience), 4-DAMP (10 mM; muscarinic receptor inhibitor; Tocris), or Rp-8-CPT-cAMPS (''Rp''; 50 mM; PKA inhibitor; Biolog) for 24 or 48 hr. Explants were either lysed for RNA or fixed for immunostaining.
Epithelial Rudiment Cultures
SMGs were harvested from E13 ICR mice, the epithelia were separated from mesenchyme using dispase treatment, and mechanical dissection and epithelial rudiments cultured in a 15 ml drop of laminin-1,1,1 (Trevigen) on nucleopore filters floating above serum-free medium (Steinberg et al., 2005) . All epithelial assays contain 400 ng/ml FGF10 (R&D Systems) and 0.5 mg/ml heparan sulfate (Sigma).
To study ductal growth and lumen formation, epithelia were also cultured with 200 nM VIP (Anaspec) or 20 mM 8-Br-cAMP (Sigma).
For lumen expansion assays, epithelia were cultured with FGF10 and 10 ng/ ml HBEGF (R&D Systems) for 28 hr before the addition of 200 mM 8-CPT-cAMP (''CPT''; PKA/Epac activator; Biolog); 200 mM 8-pCPT-2 0 -O-Me-cAMP (''007''; Epac activator; Biolog); 200 nM CCh (Sigma); or 200 nM VIP with or without 250 mM Rp-8-CPT-cAMPS (''Rp''; PKA inhibitor; Biolog), 10-40 mM CFTR172 (Sigma), or 5 mM PD168393 (EGFR inhibitor; Tocris). Epithelia were cultured another hour before fixation for immunostaining.
For PSG/epithelia cocultures, PSGs were separated from E13 SMG as for epithelia above. Approximately four or five PSGs were placed in the center quantified by measuring the luminal area and normalizing to controls (expressed as a ratio; E and G). Data are means ± SD of two experiments (n = 6; three or four glands per genotype/treatment) and were analyzed using the Student's t test; **p < 0.01; *p < 0.01. The scale bars represent 50 mm. (H) Comparison of wild-type and Cftr-deficient (S489X) salivary glands from 4-month female mice. Arrow highlights granulated duct. Glands were imaged using auto fluorescence (yellow), and nuclei were stained with DAPI (blue). (I) Schematic illustrating the role of ACh, VIP, and NRTN in regulating SMG development. See also Figure S6 . of the drop of laminin-1,1,1, and epithelia were placed <1 mm from the PSGs. The neurotrophic growth factor neurturin (10 ng/ml; R&D Systems) was added to the media to support neuronal growth and VIP expression by the PSGs (Knox et al., 2013) .
In Vivo Inhibition of VIP Receptor VIPR antagonist ([D-p-Cl À Phe 6 ,Leu 17 ]-VIP; Tocris) was injected into timed pregnant CD1 mice as described previously (Gressens et al., 1994; Passemard et al., 2011) . CD1 timed pregnant females were injected with 1.2 mg per gram of body weight of VIP antagonist or PBS (200 ml; solvent for VIPR antagonist) twice daily for 5 consecutive days (E12-E16). E17.5 salivary glands were collected, fixed, and stained as indicated below.
qPCR Total RNA samples were DNase treated (Ambion) prior to cDNA synthesis using SuperScript reagents (Invitrogen). SYBRgreen qPCR was performed using 1 ng of cDNA and primers designed using Beacon Designer software. See Supplemental Experimental Procedures for primer sequences.
Melt curves and primer efficiency were determined as previously described (Hoffman et al., 2002) . Gene expression was normalized to 29S (Rsp29) and to the corresponding experimental control. Reactions were run in triplicate and repeated three times.
Immunofluorescence Analysis
Whole-mount immunofluorescence analysis has been described (Knox et al., 2010) . Briefly, SMG and epithelia were fixed with either ice-cold acetone/ methanol (1:1) for 5 min or 4% paraformaldehyde (PFA) for 20 min followed by 0.1% Triton X-100/PBS for 10 min. For analysis of SMG older than E16, after fixation with 4% PFA, glands were embedded in optimal cutting temperature and frozen tissue sections of 15-30 mm were analyzed. Tissue was blocked 4 hr at 22 C with 10% donkey serum (Jackson Laboratories), 1% BSA, and mouse-on-mouse IgG-blocking reagent (Vector Laboratories) in 0.01% PBS-Tween-20. SMG or epithelia were incubated with primary antibodies overnight at 4 C: mouse anti-GM130 (1:500; BD Biosciences), rabbit anti-ZO1 (1:100; Invitrogen), rat anti-prominin-1 (1:200; BioLegend), rabbit anti-aPKC (C-20; 1:400; Santa Cruz Biotechnology), mouse anti-Tubb3 (clone TUJ1 at 1:400; R&D Systems), rat anti-E-cadherin (1:400; clone ECCD-2; Invitrogen), rabbit anti-cleaved caspase-3 (5A1E; 1:200; Cell Signaling Technology), or rat anti-Krt19 (1:300; tromaIII; DSHB). Antibodies were detected using Cy2-, Cy3-, or Cy5-conjugated secondary Fab fragment antibodies (Jackson Laboratories). F-actin was detected with Alexa Fluor 488 or rhodamine phalloidin (1:50; Invitrogen). Fluorescence was analyzed using a Leica Sp5 microscope and NIH ImageJ software.
Cell proliferation was detected using Click-iT EdU Imaging Systems (Invitrogen) as described by the manufacturer. Briefly, SMG or epithelia were cultured with EdU (5 mM) for 30 min, fixed with 1:1 ice-cold acetone/methanol, and then incubated with Click-iT EdU reaction cocktail for 30 min. EdU(+) cells were counted in the duct regions of individual epithelia and normalized to total number of DAPI(+) nuclei and expressed as fold increase compared to control conditions. cAMP Assay and Western Blotting For cAMP assay, epithelia were preincubated with 3,7-dihydro-1-methyl-3-(2methylpropyl)-1H-purine-2,6-dione (200 mM) before the addition of 10-500 nM VIP. After 1 hr, epithelia were lysed in 150 ml lysis buffer from the commercial enzyme-linked immunoassay kit (Cyclic AMP XP Assay kit; Cell Signaling Technology) and cAMP was measured according to the manufacturer's instructions.
Phosphorylation of CREB was assessed via western blotting. E13 epithelia cultured for 24 hr and thereafter treated with VIP (100-1,000 nM) for 15 min. Epithelia were lysed directly in 250 ml Laemmli buffer. Proteins were separated by SDS-PAGE, transferred onto the polyvinylidene fluoride membrane, and immunoblotted with specific antibodies for CREB and phospho-CREB (Cell Signaling Technology).
Live-Cell Imaging Epithelia were cultured with VIP and HBEGF for 28 hr as above. Filters were inverted and placed into 3.5 cm glass bottom dishes (MatTek). VIP (200 nM) was added to the media at the beginning of imaging. Imaging was performed on a custom-build inverted spinning disc confocal microscope based on a Nikon TI microscope stand, equipped with environmental control (In Vivo Scientific), a Boralis-modified Yokogawa CSU-X1 confocal head and LMM5 laser merge module (both from Spectral Applied Research), motorized stage (Applied Scientific Instrumentation), and perfect focus system (Nikon; Stehbens et al., 2012) . Samples were illuminated with a 100 mW 561 nm solid state laser (Cobolt Jive) and imaged using a Nikon CFI Plan Apo numerical aperture 1.2 603 water immersion objective and Andor Clara charge coupled device (CCD) camera. Image acquisition was controlled by Nikon Elements software. Optical sections were taken every 1 mm over the entire specimen at 100 ms exposure per plane and 2 min intervals. Frames were selected and z axis reconstructions prepared with the ImageJ/Fiji (http://fiji.sc/Fiji).
Morphometric and Statistical Analyses
Morphogenesis was quantified by counting the number of branches or duct length. All SMG data were obtained using four or five SMGs/group and each experiment repeated three times. Data were log transformed before all statistical analysis with GraphPad Prism 6 software (GraphPad Software). The Student's t test was used to compare two different groups and one-way ANOVA to compare more than two experimental groups. For qPCR analysis, a false discovery rate (Q) for multiple unpaired t tests was set to 5%. All graphs show the means ± SD. 
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